Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
The following search string was used: #1"Parkinson Disease"[mh] OR Parkinson* [tw]) AND #2"Glucagon-Like Peptide 1"[mh] OR"GLP-1 receptor agonists"[tw] OR"glucagon-like peptide-1"[tw] OR GLP-1 [tw] OR liraglutide [tw] OR exenatide [tw] OR dulaglutide [tw] OR semaglutide [tw] OR lixisenatide [tw]) AND #3"Metabolism"[mh] OR metabolism [tw] OR"Body Weight"[mh] OR"body weight"[tw] OR"Obesity"[mh] OR obesity [tw] OR"Diabetes Mellitus"[mh] OR diabetes [tw] OR neuroprotection [tw]) AND English [la] AND ("2000"[dp]:"2025"[dp]) Study Selection The following authors, IAO and CEV, independently reviewed the titles and abstracts of all identified articles
The researchers also couldn't account for some factors, such as socioeconomic status or lifestyle choices, that could affect the results
I have trouble reaching my upper arm, and when I used to get the Dr to do it in the arm I would have pain for hours that radiated down my arm
doi: 10.1124/pr.117.014803
However, a random forest taxa classifier was unable to predict specific bacteria associated with treatment (data not shown, random forest model accuracy = 6.25%)
US$ 25.98
US$ 28.96
US$ 28.61
US$ 28.74
US$ 24.97
